Sun Pharma and Taro terminates agreementIllustrative image – not actual.

Sun Pharmaceutical Industries and Taro Pharmaceutical Industries (Taro) are  mutually agreed to terminate their merger agreement.

The merger had announced in August 2012,  pursuant to which all shareholders of Taro (other than Sun Pharma and its affiliates) would have received a cash payment of $39.50 per share upon the closing of the merger.

Source: Pharma Biz

← All latest storiesBack to top →